Status:
COMPLETED
ALIGN Intervention in Patients With Advanced Cancer Discharging to a SNF
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
National Cancer Institute (NCI)
Icahn School of Medicine at Mount Sinai
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
This is a single arm, pre-post, pilot study assessing the feasibility and acceptability of the ALIGN intervention in metastatic adult cancer patients discharging to local area SNFs.
Detailed Description
A novel approach for delivering high quality palliative care for cancer patients discharging to a skilled nursing facility (SNF) is critically needed. This investigator plans to test a palliative care...
Eligibility Criteria
Inclusion
- Stage II - IV solid tumor malignancy
- Discharging from an acute care hospital to a SNF in the metro Denver area
- Decisional capacity to consent
- English speaking
- (During COVID requirements) Either internet access through a computer, tablet, or smartphone OR cellular service with adequate allowance of cellular minutes to allow virtual visits (by participant's assessment)
Exclusion
- 1\. Discharging with hospice as their goal of care
Key Trial Info
Start Date :
September 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2021
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04882111
Start Date
September 28 2020
End Date
November 1 2021
Last Update
November 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Hospital
Aurora, Colorado, United States, 80045